BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 10, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 19, 2018
View Archived Issues
BioWorld stock report for public biotechnology companies
Read More
This week's biggest gainers and losers
Read More
Regulatory submissions, approvals and other actions: October 2018
Read More
Conference data: October 2018
Read More
Word on the street
Read More
Week in Washington
Read More
Week in review
Read More
Biopharma money raised Jan. 1 - Nov. 14
Read More
Biotech products surge thanks to big pharma spending
Biological drugs – monoclonal antibodies, peptides, recombinant proteins and the like – now account for more than 30 percent of all FDA approvals according to a new study from the Tufts Center for the Study of Drug Development.
Read More
Money raised by biotech: 2018 vs. 2017
Read More
